Streetbeat News

Price Targets

CHWY

TD Cowen has initiated coverage on Chewy (NYSE:CHWY) with a Buy rating and set a price target of $38, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 11:19 am

GANX

HC Wainwright & Co. has reiterated its Buy rating for Gain Therapeutics (NASDAQ:GANX) and maintained a price target of $8, indicating confidence in the company's potential.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 11:14 am

NYT

Deutsche Bank has initiated coverage on New York Times (NYSE:NYT) with a Buy rating and set a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 11:12 am

HPE

Deutsche Bank has initiated coverage on Hewlett Packard (HPE) with a Hold rating and set a price target of $22.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 11:09 am

BDTX

HC Wainwright & Co. has reiterated its Buy rating for Black Diamond Therapeutic (NASDAQ:BDTX) and maintained a price target of $11.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:58 am

SAGE

HC Wainwright & Co. has reiterated a Neutral rating for Sage Therapeutics with a maintained price target of $25.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:55 am

CYTK

HC Wainwright & Co. has maintained a Buy rating on Cytokinetics and raised the price target from $90 to $120, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:48 am

INKT

HC Wainwright & Co. has reiterated its Buy rating for MiNK Therapeutics (NASDAQ:INKT) and maintained a price target of $9, indicating continued confidence in the company's potential.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:45 am

RICK

HC Wainwright & Co. has reiterated its Buy rating for RCI Hospitality Holdings (NASDAQ:RICK) and maintained a price target of $98.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:40 am

EXK

HC Wainwright & Co. has maintained a Buy rating on Endeavour Silver (NYSE:EXK) but lowered the price target from $6.25 to $6.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:29 am